Browse All
Displaying 16 - 20 of 20
Author:Bermel, Robert Killestein, Joep Berger, Thomas Brochet, Bruno Carroll, William Freedman, Mark Holmoy, Trygve Karabudak, Rana Nos, Carlos Patti, Francesco Perrin Ross, Amy Vanopdenbosch, Ludo Vollmer, Timothy Buffels, Regine Kadner, Karen Bortolami, Oscar Hartung, Hans-Peter
Session Name:P7: MS Therapeutics 1
Topic:MS and Inflammatory Disease
Program Number:P7.003
Author Institution:Mellen Center for MS, Department of Neurology, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands, Amsterdam, Netherlands Department of Neurology, Medical University of Vienna, Vienna, Austria, Vienna, Austria University of Bordeaux, Bordeaux, France, Bordeaux, France Department of Neurology, Sir Charles Gairdner Hospital, Perron Institute for Neurological and Translational Science, The University of Western Australia, Nedlands, Australia, Subiaco, Australia University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute, Ottawa, ON, Canada, Ottawa, ON, Canada Department of Neurology, Akershus University Hospital, Lørenskog, Norway, Lasker, Norway Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey, Ankara, Turkey Centre d’Esclerosi Mútiple de Catalunya (Cemcat), Vall d’Hebron Hospital Universitari, Barcelona, Spain, Barcelona, Spain Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Neuroscience Section and Multiple Sclerosis Centre, University of Catania PO Policlinico G Rodolico, Catania, Italy, Catania, Italy Loyola University Chicago, Chicago, IL, USA , Oak Brook, IL Department of Neurology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium, Brugge, Belgium Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA, Aurora, CO F. Hoffmann-La Roche Ltd, Basel, Switzerland, Toulon, France F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland Department of Neurology, UKD, Centre of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany, Dusseldorf, Germany
Author:Williams, Mitzi Airas, Laura Chitnis, Tanuja Saini, Sarbjit Hide, Michihiro Sussman, Gordon Nakahara, Jin Bermel, Robert Dörner, Thomas Loop, Brett Ziehn, Marina Willi, Roman Kieseier, Bernd C. Nikolaev, Ivan Haemmerle, Sibylle Zharkov, Artem Siegel, Richard Cenni, Bruno Wiendl, Heinz Maurer, Marcus Giménez-Arnau, Ana Montalban, Xavier
Program Number:P7.015
Author Institution:Joi Life Wellness Group, Atlanta, GA, USA, Atlanta, GA Turku University Hospital and University, Finland, Turku, Finland Brigham and Women's Hospital, Department of Neurology, Boston, MA, USA, Boston, MA Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA, Baltimore, MD Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan, Hiroshima, Japan University of Toronto, Toronto, Ontario, Canada, Toronto, ON, Canada Department of Neurology, Keio University School of Medicine, Tokyo, Japan, Shinjuku-ku, Japan Mellen Center for MS, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Department of Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin DRFZ, Berlin, Germany, Berlin, Germany Novartis Pharmaceutical Corporation, Cambridge, MA, USA, Cambridge, MA Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Novartis Pharma AG, Basel, Switzerland Department of Neurology, Heinrich-Heine University, Duesseldorf, Germany, Duesseldorf, Germany Novartis Institutes for Biomedical Research, Basel, Switzerland, Basel, Switzerland Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany, Muenster, Germany Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany, Berlin, Germany Department of Dermatology, Hospital del Mar - IMIM, Universitat Pompeu Fabra, Barcelona, Spain, Barcelona, Spain Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain
Author:Villanueva, Vicente D'Souza, Wendyl Faught, Edward Klein, Pavel Reuber, Markus Rosenow, Felix Salas-Puig, Javier Soto Insuga, Victor Strzelczyk, Adam Szaflarski, Jerzy P. Besson, Herve Daniels, Tony Floricel, Florin Laloyaux, Cedric Sendersky, Veronica Zhou, Sophia Steinhoff, Bernhard J.
Session Name:P11: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 1
Topic:Epilepsy/Clinical Neurophysiology (EEG)
Program Number:P11.003
Author Institution:Hospital Universitario y Politécnico La Fe, Valencia, Spain, Valencia, Spain Department of Medicine, St Vincent’s Hospital Melbourne, The University of Melbourne, Melbourne, Australia, Melbourne, Australia Emory Epilepsy Center, Atlanta, GA, USA, Atlanta, GA Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA, Bethesda, MD The University of Sheffield, Sheffield, UK, Sheffield, United Kingdom Epilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, Frankfurt, Germany, Frankfurt am Main, Germany Universitari Vall d’Hebron, Barcelona, Spain, Barcelona, Spain Pediatric Neurology, Hospital Universitario Infantil Niño Jesús, Madrid, Spain, Madrid, Spain Epilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, Frankfurt, Germany, Frankfurt, Germany UAB Epilepsy Center, Birmingham, AL, USA, Birmingham, AL UCB Pharma, Breda, Netherlands, Breda, Netherlands UCB Pharma, Morrisville, NC, USA, Morrisville, NC UCB Pharma, Monheim am Rhein, Germany, Monheim Am Rhein, Germany UCB Pharma, Brussels, Belgium, Brussels, Belgium Kork Epilepsy Center, Kehl-Kork and Medical Faculty, University of Freiburg, Freiburg, Germany, Kork, Germany
Author:Tur, Carmen Sun, Zhaonan Bradley, Daniel Grossman, Cynthia Montalban, Xavier Rovira, Alex Tintore, Mar Campbell, Nolan Fisher, Elizabeth
Session Name:P11: MS Neuroimaging 2
Program Number:P11.010
Author Institution:Vall d'Hebron, Barcelona, Spain Biogen Inc., Cambridge, MA
Author:Ashina, Messoud Mitsikostas, Dimos Dimitrios Amin, Faisal Kokturk, Pinar Sahin, Gurdal Schankin, Christoph J Dorman, Paul J Pozo-Rosich, Patricia Lyras, Leonidas Myers, Coleen Ahn, Andrew H Tassorelli, Cristina
Session Name:P12: Headache: Clinical Trials and Real World Studies 2
Topic:Headache
Program Number:P12.002
Author Institution:IRCCS Mondino Foundation, University of Pavia, Pavia, Italy , Pavia, Italy Danish Headache Center, University of Copenhagen, Rigshopitalet, Copenhagen, Denmark Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece Danish Headache Center, University of Copenhagen, Rigshopitalet, Department of Neurorehabilitation/Traumatic Brain Injury, Righospitalet, University of Copenhagen, Copenhagen, Denmark Department of Clinical Sciences of Lund, Lund University, Skåneuro Neurology Clinic, Copenhagen, Denmark Teva Netherlands B.V., Amsterdam, Netherlands Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland Headache Unit & Research Group, Vall d’Hebron Hospital & Research Institute, Universitat Autonoma de Barcelona, Barcelona, Spain Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
